Healthycrop: Development of fungal-resistant crops paves the way for global licensing agreements

Sales through license agreements are dependent on patents

Healthycrop’s business model consists of negotiating license agreements with large, global seed producers, who gain access to using Healthycrop’s technology. Guardian IP Consulting helps Healthycrop with patent strategy and ensures that the patent covers the plants the company would like to include in their product development.

– To obtain broad patent protection for Healthycrop, we have used strong patent/technical argumentation to convince the patent authorities. Our work for Healthycrop and other biotech companies rest on a strong research background and a deep insight into their technology and future exploitation, says Verena Simpson, European Patent Attorney, and partner at Guardian IP Consulting, who herself has many years of research experience.

Healthycrop has currently applied for a patent in the EU, USA, Canada, Brazil, and Australia. Especially the patent in the USA is very broad and covers all crops, which in addition to cereals includes soybeans and maize. And this broad coverage means the world for Healthycrop.

It means everything to us that we can protect our intellectual property rights. Without it, we wouldn’t have a business.

Pernille Ollendorff Hede
CEO I Healthycrop

The big producers can do gene editing themselves at the same level as us and they also have the large machinery to launch it. But they cannot devote the many years of research that we have been able to at Aarhus University. More than ten years of development lie behind our product, says Pernille Ollendorff Hede and continues:

– I rely enormously on Verena in our collaboration. I have a background in plant molecular biology, but I am very dependent on Verena’s patent expertise and her recommendations.